Alpine Woods Capital Investors, LLC Seres Therapeutics, Inc. Transaction History

Alpine Woods Capital Investors, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 01, 2019	SELL	$2.29 - $4.16 $240,450 - $436,800	-105,000 Closed	0 $0
Q2 2019 Aug 05, 2019	BUY	$2.28 - $7.35 $102,599 - $330,750	45,000 Added 75.0%	105,000 $338,000
Q1 2019 May 06, 2019	BUY	$4.83 - $7.21 $289,800 - $432,600	60,000 New	60,000 $412,000

40.5M

304K

471K

Ticker MCRB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 124,072,000
Market Cap $95.5M
Description
Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate that has completed Phase III clinical trial for the ...

Get notified when there are updates to the investment portfolio of Alpine Woods Capital Investors, LLC, based on Form 13F filings with the SEC.

Stay updated on Alpine Woods Capital Investors, LLC with notifications on news.